In this post, I explain how a newly introduced bias--likelihood neglect bias--can prevent us from forming accurate judgments about the world.

Truist Securities increased the price target for Vertex Pharmaceuticals (NASDAQ:VRTX) Incorporated (NASDAQ: VRTX), a $121 billion biotechnology leader, from the previous $460.00 to a new target of ...

Morgan Stanley (NYSE:MS) adjusted its outlook on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares, raising the price target from the previous $450.00 to $459.00, while maintaining an ...

Morgan Stanley analyst Terence Flynn raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $459 from $450 and keeps an Equal ...

Biotechnology company Vertex Pharmaceuticals (VRTX) reported mixed results for the fourth quarter of 2024. While revenue surpassed analyst ...

HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...

And while it will be trickier for fliers to earn points, they will find new airport lounges, some with white-glove service, and more premium flying options. In Europe, “detour destinations ...

Welsh-Iranian film-maker Sara Nourizadeh follows the story of teenage refugees Zari and Ali as they begin to rebuild their shattered lives with the help of remarkable charity worker Marjie Halati ...

After learning about this idea, I made it a habit to solve every problem by finding the third door. I became almost allergic to conformity, ignoring common wisdom. Whenever I saw someone do ...

Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...